Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.1695
+0.0012 (0.71%)
Nov 2, 2026, 3:48 PM EST - Market open
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $7.52 million as of November 2, 2026. It is the 43,003rd most valuable company in the world and the 5,762nd biggest in the United States. Its market cap has decreased by 93.78% in one year.
Market Cap
7.52M
Enterprise Value
-23.43M
1-Year Change
-93.78%
Global Rank
Country Rank
#5,762 United States
Category
ChartMarket Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has decreased from $9.30M to $7.52M, a decrease of -19.12%. That is a compound annual growth rate of -2.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 7.52M | -71.18% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 8.40M |
| Tempest Therapeutics | 8.20M |
| Ensysce Biosciences | 8.19M |
| Theriva Biologics | 7.82M |
| CollPlant Biotechnologies | 7.82M |
| Soligenix | 7.75M |
| Moleculin Biotech | 7.69M |
| MetaVia | 7.38M |